Study of [S,S]-Reboxetine in Patients With Postherpetic Neuralgia, Who Are Gabapentin Treatment Failures

A 5-Week, Randomized, Double-Blind, Placebo-Controlled Multi-Center Study Of [S,S]-Reboxetine In Patients With Postherpetic Neuralgia (PHN), Who Are Gabapentin Treatment Failures.

The purpose of this study is to determine the effectiveness of [S,S]-Reboxetine in the treatment of chronic pain following a shingles infection in patients who are Gabapentin treatment failures.

Inclusion Criteria:

• Patients must have pain present for more than 3 months after the healing of shingles skin rash.
• Patients at screening must have a score > or = 40 mm on the pain visual analogue scale.

Exclusion Criteria:

• Patients with poor renal function.
• Patients with other severe pain, that may impair the self-assessment of the pain due to shingles.
• Patients with abnormal electrocardiogram.